EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.
EKF announces the availability of a liquid, enzymatic test for glycated albumin (GA) that was recently FDA cleared for sales in the U.S. GA, used for intermediate term monitoring of glycemic control in diabetes patients, will be showcased at the 2019 AACC.
The third edition of the exhibition will be held on 25-27 September 2019 at the Palais des Expositions, SAFEX, Algiers, Algeria.
Quo-Test® HbA1c analyzer is successfully supporting improved medical management of patients with sight-threatening diabetic retinopathy (STDR).
SensLab, an EKF Diagnostics company, will be testing triathletes lactate levels at the 36th Leipzig Triathlon to be held at Kulkwitzer on the 28th July 2019.
A recent article in Nature Medicine by Scheiman et al has identified a strain of gut microbes present in marathon runners that improves run times. The scientists at Harvard and the Joslin Institute took poop samples from 15 runners at the 2015 Boston marathon.
Copyright © 2019 | Powered by Intergage